Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Francis Cano Insider Profile
4 Followers
Francis Cano, Director at Dynavax, holds 36.91K shares in Dynavax (Ticker: DVAX), holds 172.64K shares in Biomerica (Ticker: BMRA). Most recently, Francis Cano Sold ― shares of Dynavax on Jun 03, 2024 for an estimated value of 43.13K.
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+22.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Francis Cano
Francis Cano's Trading History
Dynavax
Jun 03, 2024
Director
Informative Sell
43.13K
$458.36K
Biomerica
Oct 26, 2018
Director
Uninformative Buy
18.75K
$54.21K
List of latest transactions for each holding click on a transaction to see Francis Cano's performance on stock
You May Also Like
Francis Cano insider profile FAQ
What is the percentage of profitable transactions made by Francis Cano?
The percentage of profitable transactions made by Francis Cano is 57%.
What is the average return per transaction made by Francis Cano?
The average return per transaction made by Francis Cano is 22.90%.
What stocks does Francis Cano hold?
Francis Cano holds: DVAX, BMRA stocks.
What was Francis Cano’s latest transaction?
Francis Cano latest transaction was an Informative Sell of $43.13K.
What was Francis Cano's most profitable transaction?
Francis Cano’s most profitable transaction was an Informative Buy of DVAX stock on August 12, 2019. The return on the trade was 105.00%.
What is Francis Cano's role in Dynavax?
Francis Cano's role in Dynavax is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.